p53 and ATM/ATR regulate 7,12-dimethylbenz[a]anthracene-induced immunosuppression

Molecular Pharmacology

Volumn 73, Issue 1, 2008, Pages 137-146

  Gao, Jun ^a   Mitchell, Leah A ^a   Lauer, Fredine T ^a   Burchiel, Scott W ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ATM PROTEIN; ATR PROTEIN; CYTOCHROME P450 1B1; EPOXIDE HYDROLASE; PROTEIN P53; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; FEMALE; GENOTOXICITY; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; IMMUNOTOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SPLEEN CELL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; IMMUNE SYSTEM; MICE; MICE, KNOCKOUT; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ARYL HYDROCARBON; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 37349108640     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.039230     Document Type: Article

References (40)

1. Appella E and Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268:2764-2772.
2. Bakkenist CJ and Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506.
3. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, et al. (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677.
4. Burchiel SW, Davis DA, Gomez MP, Montano RM, Barton SL, and Seamer LC (1990) Inhibition of lymphocyte activation in splenic and gut-associated lymphoid tissues following oral exposure of mice to 7,12-dimethylbenz[a] anthracene. Toxicol Appl Pharmacol 105:434-442.
5. Burchiel SW, Davis DA, Ray SD, Archuleta MM, Thilsted JP, Corcoran GB (1992) DMBA-induced cytotoxicity in lymphoid and nonlymphoid organs of B6C3F1 mice: relation of cell death to target cell intracellular calcium and DNA damage. Toxicol Appl Pharmacol 113:126-132.
6. Buters J, Quintanilla-Martinez L, Schober W, Soballa VJ, Hintermair J, Wolff T, Gonzalez FJ, and Greim H (2003) CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis 24:327-334.
7. Buters JT, Sakai S, Richter T, Pineau T, Alexander DL, Savas U, Doehmer J, Ward JM, Jefcoate CR, and Gonzalez FJ (1999) Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci U S A 96:1977-1982.
8. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, Appella E, Kastan MB, and Siliciano JD (1998) Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679.
9. Caspari T (2000) How to activate p53. Curr Biol 10:R315-317.
10. Chao C, Saito S, Anderson CW, Appella E, and Xu Y (2000) Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci U S A 97:11936-11941.
11. Dertinger SD, Nazarenko DA, Silverstone AE, and Gasiewicz TA (2001) Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo[a]pyrene- and cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis 22:171-177.
12. Dipple A and Nebzydoski JA (1978) Evidence for the involvement of a diol-epoxide in the binding of 7,12-dimethylbenz(a)anthracene to DNA in cells in culture. Chem Biol Interact 20:17-26.
13. Gao J, Lauer FT, Dunaway S and Burchiel SW (2005) Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity. Toxicol Sci 86:68-74.
14. Gao J, Lauer FT, Mitchell LA, and Burchiel SW (2007) Microsomal expoxide hydrolase is required for 7,12-dimethylbenz[a]anthracene (DMBA) induced immunotoxicity in mice. Toxicol Sci 98:137-144.
15. Gately DP, Hittle JC, Chan GK, and Yen TJ (1998) Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity. Mol Biol Cell 9:2361-2374.
16. Heidel SM, MacWilliams PS, Baird WM, Dashwood WM, Buters JT, Gonzalez FJ, Larsen MC, Czuprynski CJ, and Jefcoate CR (2000) Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene. Cancer Res 60:3454-3460.
17. Hickman ES, Moroni MC, and Helin K (2002) The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 12:60-66.
18. Ikegwuonu FI, Christou M, and Jefcoate CR (1999) Regulation of cytochrome P4501B1 (CYP1B1) in mouse embryo fibroblast (C3H10T1/2) cells by protein kinase C (PKC). Biochem Pharmacol 57:619-630.
19. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, and Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4:1-7.
20. Keegan KS, Holtzman DA, Plug AW, Christenson ER, Brainerd EE, Flaggs G, Bentley NJ, Taylor EM, Meyn MS, Moss SB, et al. (1996) The Atr and Atm protein kinases associate with different sites along meiotically pairing chromosomes. Genes Dev 10:2423-2437.
21. Khosravi R, Maya R, Gottlieb T, Oren M, Shiloh Y, and Shkedy D (1999) Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A 96:14973-14977.
22. Kurz EU and Lees-Miller SP (2004) DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 3:889-900.
23. Lakin ND and Jackson SP (1999) Regulation of p53 in response to DNA damage. Oncogene 18:7644-7655.
24. Lavin MF, Birrell G, Chen P, Kozlov S, Scott S, and Gueven N (2005) ATM signaling and genomic stability in response to DNA damage. Mutation Res 569:123-132.
25. Meek DW and Knippschild U (2003) Posttranslational modification of MDM2. Mol Cancer Res 1:1017-1026.
26. Melino G, Bernassola F, Ranalli M, Yee K, Zong WX, Corazzari M, Knight RA, Green DR, Thompson C, and Vousden KH (2004) p73 Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation. J Biol Chem 279:8076-8083.
27. Melino G, De Laurenzi V, and Vousden KH (2002) p73: friend or foe in tumorigenesis. Nat Rev Cancer 2:605-615.
28. Miyata M, Kudo G, Lee YH, Yang TJ, Gelboin HV, Fernandez-Salguero P, Kimura S, and Gonzalez FJ (1999) Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J Biol Chem 274:23963-23968.
29. Myers JS and Cortez D (2006) Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J Biol Chem 281:9346-9350.
30. Norbury CJ and Hickson ID (2001) Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol 41:367-401.
31. Page TJ, O'Brien S, Holston K, MacWilliams PS, Jefcoate CR, and Czuprynski CJ (2003) 7,12-Dimethylbenz[a]anthracene-induced bone marrow toxicity is p53-dependent. Toxicol Sci 74:85-92.
32. Pelkonen O and Nebert DW (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 34:189-222.
33. Prives C and Hall PA (1999) The p53 pathway. J Pathol 187:112-126.
34. Roos WP and Kaina B (2006) DNA damage-induced cell death by apoptosis. Trends Mol Med 12:440-450.
35. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155-168.
36. Sugiyama T, Osaka M, Koami K, Maeda S, and Ueda N (2002) 7,12-DMBA-induced rat leukemia: a review with insights into future research. Leuk Res 26:1053-1068.
37. Thurmond LM, House RV, Lauer LD, and Dean JH (1988) Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro. Toxicol Appl Pharmacol 93:369-377.
38. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY, Taya Y, Prives C, and Abraham RT (1999) A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 13:152-157.
39. Uno S, Dalton TP, Derkenne S, Curran CP, Miller ML, Shertzer HG, and Nebert DW (2004) Oral exposure to benzo[a]pyrene in the mouse: detoxication by inducible cytochrome P450 is more important than metabolic activation. Mol Pharmacol 65:1225-1237.
40. Yang J, Yu Y, Hamrick HE, and Duerksen-Hughes PJ (2003) ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses. Carcinogenesis 24: 1571-1580.